Background/Aims As the optimal stereotactic body radiation therapy (SBRT) modality
for hepatocellular carcinoma (HCC) has not been confirmed, we aimed herein to provide a
practical guideline by our retrospective review.
Methods Thirty-nine patients with primary HCC who underwent liver SBRT via 3 modalities
(helical tomotherapy [HT]: 22, volumetric modulated arc therapy [VMAT]: 13, Cyberknife: 4)
at our institution between July 2014 and July 2015 were included. Modalities were compared
with regard to dose conformity index (CI), homogeneity index (HI), clinical results, and patient
compliance.
Results VMAT SBRT had favorable conformity (CI: 0.7±0.2), homogeneity (HI: 1.1±0.0), and
shortest treatment time (100.2±26.1 seconds). HT SBRT yielded good dosimetric outcomes,
especially in conformity (CI: 1.0±0.2). Although the Cyberknife SBRT synchrony system allowed
real-time tumor targeting, the treatment time was longest (3,015.0±447.3 seconds), invasive
pre-treatment procedures were required, and the HI (1.3±0.0) was lowest.
Conclusions All 3 modalities yielded competent dosimetric planning parameters. VMAT
SBRT was most appropriate for tumors with residual lipiodol or patients with poor conditions.
HT SBRT is available for multiple or irregular targets. Cyberknife SBRT is recommended for
carefully selected patients and tumors indicated for sono-guided fiducial insertion.
Citations
Citations to this article as recorded by
Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor Anirut Watcharawipha, Somvilai Chakrabandhu, Anupong Kongsa, Damrongsak Tippanya, Imjai Chitapanarux Journal of Applied Clinical Medical Physics.2023;[Epub] CrossRef
Bone metastases in hepatocellular carcinoma (HCC) are usually treated with non-operative procedures such as radiotherapy,
hormonal therapy, bisphosphonates, or sometimes with surgical procedures. Here we describe a case with 3rd cervical spine
metastasis of HCC. A 62-year-old female with liver cirrhosis presented with neck pain. After evaluation, the patient was
diagnosed of hepatocellular carcinoma with cervical spine metastasis. The metastatic lesion was treated with tomotherapy
while the primary lesion in the liver was treated with transarterial chemoembolization using drug-eluting beads, and the
patient is tolerable waiting for the next treatment.
Extracranialoligometastasis is most common in lung, liver and bone. The standard treatment is systemic
chemotherapy but the value of chemotherapy is limited. So, we can suppose the beneficial effects from the addition
of local therapy such as metastasectomy, cooling or heating method of tumor and radiotherapy. Stereotactic body
radiotherapy is an alternative approach for surgically unresectable lesions because of proximity to blood vessels
or other critical structures and multilobar involvement and for the medically inoperable patients or patients who
do not require surgery. Extrahepatic metastasis from hepatocellular carcinoma has no general agreement on the
optimal treatment strategy. Helical tomotherapy, a new type of dynamic radiotherapy, is an intensity modulated
radiotherapy system equipped with megavoltage computed tomography image guidance. We can precisely deliver
high dose of radiation to the tumor with maximal sparing of around normal tissue and simultaneously irradiate
the multiple tumor using tomotherapy. We introduce the clinical experience of tomotherapy in oligometastasis and
metastatic hepatocellular carcinoma for the last several years.